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Absract 
 
Antimicrobial resistance in developing countries has long been an issue of major concern. Nanotechnology has 
become an eye opener for the intervention on multiple drug resistance organisms. In this study we investigated the 
antimicrobial potentials of Silver Nitrate (nanorods) solution used in managing infectious diseases, the Minimum Inhibitory 
Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of the product against microbial isolates were 
determined using standard microbiological techniques. The mean MIC and MBC of silver nitrate solution on fungi (0.16 
μg/ml and 0.29 μg/ml respectively) was significantly lower than that of Gram positive organisms (2.35μg/ml and 2.62μg/ml) 
and Gram negative organisms (2.05 μg/ml and 2.10 μg/ml). Of all the Gram positive organisms, Staphylococcus spp recorded 
the lowest mean MICand MBC while in the Gram negative organisms group, E. coli isolates showed the lowest  mean MIC 
and MBC of the silver nitrate solution, though not significantly different from the other isolates. In conclusion, results from 
this study revealed that Silver Nitrate(nanorods) may have  be broad spectrum in activity, but with higher antifungal 
potentials.  
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Introduction 
 
Antimicrobial resistance is an increasing problem in the practice of infectious disease.The emergence and spread of 
antibiotic resistance is also an alarming concern in clinical practice (Coloumbus, 1998). Nanotechnology, a new technology 
of impregnation of silver nanoparticles is enabling a wider range of medical products to be available to clinicians (Furno et 
al., 2004). Silver nanoparticles are being coated on materials and medical devices as prophylaxis to prevent bacteria from 
growing or for therapeutic use (Darouiche, 1999).The use of metallic silver has long been recognised, medical uses of silver 
includes incorporation into wound dressing, to treat external infections, used as antiseptic disinfectant in medical appliances 
such as urinary catheters, endotracheal breathing tubes where the silver content is effective in reducing incidences of urinary 
tract infections and ventilator-associated pneumoniae (VAP) (Saint et al., 1998).  
Dilute solutions of silver nitrate had been used to treat infections and burns before the introduction of silver 
sulphadiazine cream (Fox, 1998). Silver nitrate is a broad spectrum agent, bacteriostatic at a concentration of 0.5% is 
effective in prophylactic use in second and third degree burns,development of resistance to silver ion is distinctly uncommon 
(Moyer et al., 1965). Silver and silver compounds have an oligodynamic effect and are toxic to bacteria, algae and fungi in 
vitro, among heavy metals that have this effect, silver is least toxic to humans and the antibacterial actions is independent on 
the silver ion (Lansdown, 2006). 
 
Materials and methods 
Study design 
 
 This study was carried out in Niger Delta University, Bayelsa state, clinical isolates obtained from clinical 
specimens obtained from medical laboratories in the state. The silver nitrate solution or silver colloidal was obtained from 
Innovative Biotech. Laboratory, Keffi/Abuja. 
 
Microbial Isolation and Identification 
 
Sixty nine (69) isolates comprising of 19 fungi, 27 Gram positive and 23 Gram negative bacteria were used in this 
study. The isolation of microbes was done culturally using Mac conkey, blood agar,mannitol salt agar, nutrient agar and 
sarboraud dextrose agar, microbial identification was carried out using standard bacteriological techniques which include 
Gram staining of the isolates, Biochemical testing i.e Coagulase, Catalase, Citrate utilization, Indole production,oxidase 
test,Sugar fermentation tests, Germ tube test. 
 
Minimum inhibitory concentration (MIC) testing (Tube Dilution Method) 
 
A pure culture of was grown in Mueller-Hinton broth. The cultures were standardized using standard 
microbiological techniques to have a concentration of 106 cells per milliliter. Dilutions (ten-fold, two-fold and ¾-fold as the 
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case may be) of the silver nitrate nanorods stock were made in Mueller-Hinton broth. After the antimicrobial agent was 
diluted, a volume of the standardized inoculums equal to the volume of the diluted antimicrobial agent was added to each 
dilution vessel, bringing the microbial concentration to approximately 500,000 cells per milliliter. The inoculated, serially 
diluted silver nitrate solution was incubated at 37oC for 18 hours. After incubation, the series of dilution vessels were 
observed for microbial growth, usually indicated by turbidity and/or a pellet of microorganisms in the bottom of the vessel. 
The concentration in the last tube in the dilution series that did not demonstrate growth corresponded with the minimum 
inhibitory concentration (MIC) of the Silver nitrate solution. 
 
Minimum Bactericidal Concentration (MBC) 
 
From the MIC test tubes series where turbidity or sign of microbial growth were not visible, subculture were made 
onto Mueller-Hinton agar plates noting their respective concentration. The concentration in the last tube series from which 
subculture did not show growth was recorded as the MBC. 
 
 
Results      
 
Of the 69 isolates analyzed, the mean MIC of the silver nanorod was 1.70 µg/ml, 2.75 µg/ml and 2.62 µg/ml on 
Staphylococcus sp, Streptococcus spp and Bacillus spp respectively while a MBC of 2.0 µg/ml, 3.25 µg/ml and 2.62 µg/ml 
was obtained against the above mentioned organisms respectively. E. coli, Klebsiella pneimoniae, Pseudomonas spp, Proteus 
spp, and Citrobacter spp were all inhibited at a least mean concentration of 2.0 µg/ml, 2.50 µg/ml, 2.15 µg/ml, 2.62 µg/ml, 
and 1.0 µg/ml respectively. Candida spp were all inhibited at the least mean concentration of 0.16 µg/ml. There was no 
significant difference between the MIC and MBC of the silver nanorods on the various bacterial isolates (P≥0.05) (Table 1). 
The mean MIC and MBC of the silver nitrate solution on Gram positive, Gram negative and fungal isolates were 2.35 µg/ml 
and 2.62 µg/ml, 2.04 µg/ml and 2.10 µg/ml , and 0.16 µg/ml and 0.29 µg/ml respectively. The mean MIC and MBC of the 
silver nitrate solution on fungal isolates were significantly higher than those of Gram positive and Gram negative organisms, 
(P≤0.05) (Table 2). 
 
 
 
Table 1: Mean MIC and MBC of the silver nitrate solution against microbial isolates 
ORGANISM      (n) MEAN MIC (µg/ml) MEAN MBC (µg/ml) 
Staphylococcus spp   (13) 1.70 2.0 
Streptococcus spp      (8) 2.75 3.25 
Bacillus spp                (6) 2.62 2.62 
E. coli                         (7) 2.0 2.0 
Kliebsella spp             (7) 2.50 2.50 
Pseudomonas spp       (5)  2.15 2.15 
Proteus spp                 (3)  2.62 2.62 
Citrobacter spp           (1)  1.00 1.25 
Candida spp                 (19) 0.16 0.29 
 
 
 
Table 2:  Mean MIC and MBC of silver nitrate solution by cell type 
ORGANISM MEAN MIC (µg/ml) MEAN MBC (µg/ml) 
Gram Positive Organisms 2.35 2.62 
Gram Negative Organisms 2.04 2.10 
Fungi 0.16 0.29 
 
 
 
Discussion 
 
Silver particles over years have been included into many medical preparations. Although usually used on skin and 
other surfaces, silver nitrate particles are now prepared in form of food supplement which are administered orally to manage 
a sizeable number of ailments. Findings from this showed that silver nanorods have both antifungal and antibacterial 
activities as it was found to inhibit growth of Staphylococcus aureus, streptococcus spp, Bacillus spp, E. coli, Klebsiella spp, 
Proteus spp, Citrobacter spp Pseudomonas spp and Candida spp at very low concentrations. These observations are in line 
with findings of Atiteh et al., (2007); Qin, (2005); Hermans (2006) who reported that Silver kills bacteria in external wounds 
in living tissue, so physicians use wound dressings containing silver sulfadiazine (Ag-SD) or silver nanomaterials to treat 
external infections.  Although Staphylococcus spp exhibited the lowest MIC among Gram positive cocci (GPC). E. coli also 
exhibited the lowest MIC among Gram Negative Bacilli (GNB), this was similar to previous findings reported by Kim et al., 
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(2007) and Kenneth et al., (2010). In general, the silver nitrate solution exhibited a significantly higher antifungal activity 
than antibacterial. This obviously could be due to differences in cellular composition of fungi and bacteria. Kenneth et al., 
(2010) reported that silver nanorod inhibits DNA function by interracting with protein-rich membrane and could also attack 
the respiratory chain. Several researchers have reported the side effects of these nanorod products by establishing threshold 
beyond which they may become toxic or predispose one to cancer, to circumvent their health hazards, they are produced in 
very small size particles (nanometer) to enable their excretion by the body. 
 In conclusion,  advance in nanotechnology has enabled us to utilize particles in the size of nanoscale, this has 
created new therapeutic horizons as silver revealed the surface of the potential benefits and the wide range of applications. 
The most important goal is to increase adherence to basic infection control policies and procedures.   
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